NCT07844239

Brief Summary

The primary objective of this research is to study direct electrical stimulation of central autonomic network for blood pressure control.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
3mo left

Started Sep 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Sep 2026Dec 2026

Study Start

First participant enrolled

September 1, 2026

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

September 22, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 28, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

September 28, 2026

Status Verified

December 1, 2025

Enrollment Period

4 months

First QC Date

September 22, 2026

Last Update Submit

September 22, 2026

Conditions

Keywords

blood pressure controlcentral autonomic neural networkdirect electrical stimulationhypertension

Outcome Measures

Primary Outcomes (1)

  • blood pressure

    Blood Pressure is defined as the blood pressure measurement obtained 30 minutes after the completion of direct electrical stimulation.

    up to 4 hours

Study Arms (1)

Direct electrical stimulation

EXPERIMENTAL

Patients with hypertension and drug-resistant focal epilepsy who underwent intracranial monitoring via stereotactically implanted depth electrodes (SEEG) are assigned to Direct electrical stimulation for 30 sec per mission.

Other: direct electrical stimulation

Interventions

The intervention consists of direct electrical stimulation delivered at three distinct frequencies (10 Hz, 50 Hz, and 120 Hz). A double-blind design will be employed to randomly assign one of these frequencies for a 30-second direct electrical stimulation session in each patient.

Direct electrical stimulation

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Aged 18-60 years, with no gender restrictions.
  • Free from severe systemic diseases.
  • Patients who have undergone stereoelectroencephalography electrode implantation.
  • Patients who have been informed of potential risks, consented to participate in this study, and signed the informed consent form.
  • Daytime clinic blood pressure fluctuates within the following range: 90 mmHg \< systolic blood pressure \< 140 mmHg; 60 mmHg \< diastolic blood pressure \< 90 mmHg.

You may not qualify if:

  • Patients with scalp electrode hematoma or sub-electrode effusion after intracranial electrode implantation, who are unable to receive electrical stimulation.
  • Patients with intracranial structural lesions (e.g., encephalomalacia foci, vascular malformations, space-occupying lesions, etc.).
  • Pregnant women.
  • Patients who are unable to cooperate due to mental disorders or other causes.
  • Patients who have participated in other clinical trials within the past 3 months.
  • Patients who apply to withdraw from this clinical trial for any reason.
  • Patients with cardiac or pulmonary insufficiency.
  • Patients with white coat effect are excluded.
  • Patients with low cerebrovascular risk assessed by cranial magnetic resonance imaging (MRI).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hypertension

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Liankun Ren, MD

    Xuanwu Hospital, Beijing

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 22, 2026

First Posted

September 28, 2026

Study Start

September 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

September 28, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share